HomeKYMR • NASDAQ
add
Kymera Therapeutics Inc
Previous close
$33.97
Day range
$33.85 - $35.37
Year range
$9.60 - $45.31
Market cap
2.10B USD
Avg Volume
645.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 47.88M | 196.70% |
Operating expense | 14.23M | 22.27% |
Net income | -14.37M | 58.79% |
Net profit margin | -30.01 | 86.11% |
Earnings per share | -0.25 | 57.63% |
EBITDA | -18.80M | 50.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 374.88M | -7.93% |
Total assets | 575.76M | -4.54% |
Total liabilities | 180.79M | 60.01% |
Total equity | 394.97M | — |
Shares outstanding | 61.11M | — |
Price to book | 4.78 | — |
Return on assets | -8.56% | — |
Return on capital | -10.10% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -14.37M | 58.79% |
Cash from operations | 8.04M | 120.35% |
Cash from investing | 18.95M | 138.16% |
Cash from financing | 1.93M | -0.97% |
Net change in cash | 28.93M | 133.16% |
Free cash flow | -4.73M | 86.51% |
About
Founded
2015
Headquarters
Website
Employees
187
